NO. The Brookings Institution, in collaboration with the FDA’s Center for Devices and Radiologic Health (CDRH), has proposed a seven-year plan to develop and implement a National Medical Device Postmarket Surveillance System (MDS), to collect and store information about the safety, effectiveness, and quality of devices. Post-market clinical follow-up studies are one of several options available in a post-market surveillance programme (see GHTF SG2N47) and contribute to the risk management process. Therefore, systematic Post‐Market Clinical Follow‐up (PMCF) studies are an essential tool in assessment of In case you are looking for post-market surveillance or other actions necessary to ensure compliance of your medical products, feel free to further explore Decomplix services here. ${��=iˑ��H�p�E�0�t y��X!R$x2d12�@7[�F$�Q�"��? endstream endobj 147 0 obj <>>>/Metadata 70 0 R/OpenAction 148 0 R/Outlines 100 0 R/PageLayout/TwoPageRight/Pages 142 0 R/Type/Catalog/ViewerPreferences<>>> endobj 148 0 obj <> endobj 149 0 obj <>/ExtGState<>/Font<>/ProcSet[/PDF/Text/ImageC]/Properties<>/XObject<>>>/Rotate 0/Tabs/W/Thumb 56 0 R/TrimBox[0.0 0.0 595.276 841.89]/Type/Page>> endobj 150 0 obj <>stream The rationale for establishing a process to do this is; (a) the PMS plan is potentially complex and may involve several stakeholders, (b) if the manufacturer has more than one device, the process will need be repeated for every device or family of similar devices, (c) it has to be … with data obtained from the post -market surveillance. 10 0 obj %���� �"A)t�&������*�n%�H@2�=�@ F�H�� <> 167 0 obj <>/Filter/FlateDecode/ID[<7AEA906CC94D624F8F0BF210EAEC2ED8><2F0FC5E230BBBC49A24E60C322567FA9>]/Index[146 33]/Info 145 0 R/Length 98/Prev 1595746/Root 147 0 R/Size 179/Type/XRef/W[1 2 1]>>stream A Post Market Surveillance Report on a device manufacturer or device provides Product Liability Insurance Companies with the comprehensive adverse event metrics and trends they need to write better policies and reduce their risk. endobj Under section 522 of the Federal Food, Drug and Cosmetic Actin the Safe Medical Devices Act of 1990 (SMDA), the FDA is authorized to require manufacturers to conduct PMS for certain class II and class III medical devices. stream %PDF-1.7 %���� Two types of study designs are often used: the cohort study and the case -control study. Introduction to Post-marketing Drug Safety Surveillance: Pharmacovigilance in FDA/CDER LCDR Monica Muñoz, PharmD, MS, BCPS . h�b```b``Vd`e`�ae@ Q�G��@GS��iZAf��� ,� �KNj�k ��`�n�{�#w°�Z��d�����"�yc�\͐���CV�X��G�S`�u�+W��� ����/]7@�c��9g�ñ�aJ��3��@Ƃ $2'׵;��L��l�^���-3r U��8��t�xEG�f,R�`R��L�C��W HFw�S9��v4*@�*���c@Z��A�Ø� ����\� b�x�AZ�q;���q�\��/�) �;X�Z�73030�2002p^�y�����������z�m �l ��T�E����$��[��� �0��3�00�]V�° �J3 �# m� �b�3݁k�`��(��� � n�@ <>/ExtGState<>/XObject<>/ProcSet[/PDF/Text/ImageB/ImageC/ImageI] >>/MediaBox[ 0 0 595.32 841.92] /Contents 4 0 R/Group<>/Tabs/S/StructParents 0>> GUIDELINE ON POST MARKETING SURVEILLANCE CONTENTS 1. h�bbd``b`�$^ F+ �� $v H0�: BDȂ� BD��\g�W��X$��@F�B[A{��&F%�E�D�Ӿ d�A POST MARKETING SURVEILLANCE PLAN Medical Devices Regulatory Division National Medicines Regulatory Authority Sri Lanka Introduction A precondition for placing a product on the market is that conformity to the relevant Essential Requirements, including a favorable benefit/risk ratio, has been demonstrated. 2 0 obj Post Marketing Surveillance Guideline Effective Date: 15/10/2019 Version and Revision Number/Code: V 1.0 / Rev No :0 Page 2 of 8 Once PRINTED, this is an UNCONTROLLED DOCUMENT. �@t��]��'gW0���Q�3-�3u ���Zj�ÙR% Ww�^?��� l�`FA?lIħ���vD� [*�� 㠟�W���������5y����wM��ϩ��A�Ep�q��X�,��2�D�h(�l"L��I�Z+9W~���FZ�䶍�c���\�Z}r���F1�O��; • The “life cycle” approach to health product regulation needs to be supported by enhanced post-market oversight. endobj Post-marketing surveillance of drugs therefore plays an important role to discover undesirable effects that might present a risk. 3 0 obj PMS is a collection of processes and activities used to monitor the performance of a medical device. Post-market surveillance activities have raised questions about safety, clinical performance, or effectiveness. 9 0 obj These activities are designed to generate information regarding use of the device to expediently identify device design and/or usage problems and accurately characterize the real-world device behaviour and clinical outcomes. :K�\ECl��&dl��a��$�p��6෋��'2�Øn�+�ߑ]��h�%�!�K>�xD�����_��r)�'Bk�)"3+�e�o �׷Cك8%��*����/�bxsΊ�:�� �C�U�0*/�O����M��P`��� ��?��gz5|��d�ѓ O��\��)$1�I������s�"��N�o�qe���?��*z��s;�^��{{����C�b=+@쬴~e.��B�miI��|��ڑ����h����ڢEn䷩�2Ѷ�;&��у�� ��JTy��)3X�@O�=|������T`����~3�_�g���z����6�yX��4T�E�lv�X��(l y"T�55u�]�m�tge�,2�������h]�;F�E�kŚ�ؔa�̎v�1+�QM�g���"QWE�����l�%���W��[�� endobj x��VmoG�����w�Y��vO�"a � �[EQ>\lL�������3{w�ݝ��"�3���<3;���r���ޯ���vg�J���>��v�x��N�y��o������ׅ�� �8}��8��0%�i�b �i���;�7�I���(@HH� 2� @K��&�hq5�0��Na�g.�]5_�A�K��G_�����F[��t�]��b�Z1�|�>�3���K:��n����u:�A0��:w��cG;��2k� *��=HqR�)އ�E�+�� Ensuring continued acceptability of identified risks 3. Post-marketing Surveillance of Drugs . <>/Metadata 512 0 R/ViewerPreferences 513 0 R>> Article 84 requires that the PMS System is based on a plan, although the details of the plan are specified in Annex III, 1.1. 146 0 obj <> endobj %%EOF endobj ���@����.��;�@ �3�,��K藾g�FU�]@ ���K��Ѯxώ�� ��t+�y���O�]���Oipy�zv��P�`5� �G��\��-��� ����i�g\��������y��+�w��½��C�.dW|*��`9��j����� �9�b�>���=�����n[>��j�����'. If properly developed and implemented, the EU PMS plan will function as a key player in the establishment of a new framework for proactive safety evaluation of medical devices. It is important that manufacturers do not overlook post-market surveillance compliance regulations, because regulatory bodies across the globe are increasingly imposing more demanding and prescriptive requirements. endobj To meet MDR requirements, device manufacturers should design and run PMCF studies with three major goals in mind: 1. h޴V�n�6����(�����_��mn�s�y�%�V#K�Dg���I�[I�}(^g8s8�9U �U)���c�)aL��gn� Oc�Mp"�OŊ�H1�Ą )���0����)�������TY������6� Post-Marketing Surveillance Introduction Post-marketing surveillance refers to the search for adverse reactions to drugs that have been cleared for general use. Introduction – Post Market Surveillance & Adverse Event Reporting. The clinical in… and post market oversight of these products. The plan identifies the process and frequency of activities for gathering post-market data as an input into clinical evaluations and risk analysis to be included in your technical documentation for a medical device CE Marking application. TGA’s required post -market surveillance system • Post-market monitoring of compliance by the TGA • Vigilance programs, such as incident reporting The TGA monitors and regulates devices throughout their life cycle . <> 1 INTRODUCTION DOC. Post-market surveillance, vigilance and market surveillance requirements of the MDR will apply after the date of application: 26th May 2021. endobj endstream In this post, we will try to summarize all you have to know in order to design Post Marketing Surveillance – PMS and Post Marketing Clinical Follow Up – PMCF plan for your medical device in compliance with the new EU medical device regulations – MDR.. Let’s start from the basics and try to understand what these two quality documents: post marketing surveillance plan and PMCF plan … Division of Pharmacovigilance 13 If pre-CE-marking safety and clinical performance study did not or could not sufficiently address certain aspects. Post-Marketing Surveillance – Alternative definition – Systematic business research project to collect and review data from the experience gained from medical devices placed on the market and to define actions by analyzing this experience data 8 0 obj endobj 0 �˼b��ei�Z����_��^@w�C ��a�,$~�b��-w…�䩣F SURVEILLANCE OF DRUGS Post-marketing surveillance (PMS) to assure the quality, efficacy and safety of drugs after they go on the market and to establish proper methods of use of drugs consists of three systems: the ADRs and infections collection and reporting system, the reexamination system, and the reevaluation system (Fig. 5 0 obj x��\���gK�eaw���Җ�A�*�H���1v�={/QQ������ʋi��)�ZR�D�Q4V0������̰��c|��9>��ܙ�{�7g�{�@ �*�*�0�0 I]�d�E�6#�^E Despite CDER's vigilant premarket review, active postmarketing surveillance of drug adverse effects is also essential. <> 4 0 obj 13 178 0 obj <>stream In case the relationship between the plan and the processes listed Article 83 was not already clear, Annex III 1.1 starts with a reminder: “The manufacturer shall prove in a post-market surveillance plan that it complies with the obligation referred to in … These are: 1. devices where failure would have serious adverse health consequences 2. devices that are implanted within the body for more than one year 3. devices intended to be life-sustaining or life-supporting being used outside a facility 4. devices e… Session A3: Post-Market Vigilance Activities . This PMS plan template outlines the content for a post-market surveillance plan. How Decomplix can help. stream Detecting emerging risks on the basis of factual evidence In addition, according to MEDDEV 2.12-2 rev 2,each PMCF study should have a clinical investigation plan describing the design and methodologies of the planned study. endstream endobj startxref endobj Post-Market Monitoring Report 2012 Amylopectin Potato EH92-527-1 BASF REG. endobj Medical Devices: Post Market Surveillance: National Competent Authority Report Exchange Criteria and Report Form: GHTF/SG2/N79R11:2009 Study Group 2 – Final Document _____ Serious Public Health Threat or Concern Any event type, which results in imminent risk of … 6 0 obj ����ʢܟ�. 11 0 obj �ެ�]Kk�_oq ���A������"�Jt�OGiI��V7����G ����! Hello, Based on MEDDEV 2.12-2 Guidelines on post Market clinical follow-up (May 2004), Post market surveillance (PMS) included variouse aspects such as complaint handling, vigilance, customer survey, post market clinical follow-up, etc. <> %PDF-1.7 Conformity assessment: “Conformity assessment, conducted before and after a medical device is placed on the market, and post-market surveillance of devices in actual use are complementary elements of the GHTF global regulatory model. Most postmarket surveillance submissions should include the following elements: “Background (e.g., regulatory history, brief description of the device, indications for use) Purpose of the postmarket surveillance plan (i.e., public health questions from 522 order) Postmarket surveillance plan objectives and hypotheses Post Market Surveillance (PMS) is primarily concerned with establishing the PMS plan for the device. Post-market clinical studies are not intended to replace the pre-market data necessary to make the decision as to approve the device. 2013/7000588 Page 5 of 19 2. Post-market surveillance (PMS) is defined as " a systematic process to derive necessary corrective and preventive actions (CAPA) from information on … Assist with creating your PMCF plan and necessary documentation. In the recent revision (MEDDEV 2.12/2 rev2) published on January 2012, post-market clinical follow-up STUDIES have been … <> The new European Union (EU) postmarket surveillance (PMS) plan may serve as a thorough tool for the benefit-risk evaluation of medical devices. • The need for a proactive and systematic approach to obtaining and evaluating evidence in support of both the benefits and risks of health products. Post-marketing surveillance studies provide additional information on the benefits and risks of a drug, resulting in possible drug safety hazards being <> Post-marketing surveillance (PMS) to assure the quality, efficacy and safety of drugs after they go on the market and to establish proper methods of use of drugs consists of three systems: the ADRs and infections collection and reporting system, the reexamination system, and the reevaluation system (Fig. Post marketing surveillance can further refine, or confirm or deny, the safety of a drug after it is used in the general population by large numbers of people who have a wide variety of medical conditions. So here post‐market surveillance plan becomes the only key for identification and investigation of residual risks associated with the use of medical device placed on the market by use. '�Ѝ& In a cohort design, a <> By Suzanne Hodsden. 7 0 obj ��C!T��,e5� endobj �X� �(���ڗx�o���=�ڃ�t6z(vB���t�Y��y����I�-�ۀ��1K_9�1��`Ћ,�2�f��N��`���O�1�B熦� %~9�H���6��D��u0�/>���)�c. Why Is A Post-Market Surveillance Plan A “Hot Button” with Auditors recently? <> Refer to NMRA website for latest version. �!��5+�͉ %�7?\���'MR�҉��t���.�dJ��bk��My�f�Dح�AsÜ. Because all possible side effects of a … Where post-market clinical follow -up as part of the post-market surveillance plan for the device is not deemed necessary, this must be duly justified and documented. Confirming device safety and clinical performance 2. Post Market Surveillance Article 10, 9. lays down the requirement for all Manufacturers to have a Post Market Surveillance (PMS) System. Post-market surveillance is the practice carried out by medical device manufacturers to monitor the safety of a product once it has been released to market. <> EXECUTIVE SUMMARY Post-market monitoring was conducted for amylopectin potato EH92-527-1, variety Amflora, according to the monitoring plan as contained in Amflora Notification 1 0 obj }��/�D���9�ia�\�@"stw��K�)V��?����� �,x.H�+�k�yVP�H|��A1���N�xv� The main elements of which detailed in Article 78 (the PMS system), Article 79 (the PMS Plan), Article 80 (the PMS report – for lower risk devices) and Article 81 (the Periodic Safety Update Report (PSUR) - for higher risk devices). PMO-1.10 Surveillance Plan Table of Contents February 2009 LIST OF ACRONYMS ANSI/EIA American National Standards Institute/Electronics Industrial Alliance CA Control Account CAM Control Account Manager CBB Contract Budget Baseline CPR Contract Performance Report CWBS Contractor Work Breakdown Structure DCAA Defense Contract Audit Agency DCMA … Present a risk surveillance Article 10, 9. lays down the requirement for all Manufacturers to have a Market! Clinical studies are not intended to replace the pre-market data necessary to make decision! ���O�1�B熦� % ~9�H���6��D��u0�/ > ��� ) �c safety and clinical performance study did not or could not sufficiently certain... Monica Muñoz, PharmD, MS, BCPS ) is primarily concerned with establishing the plan! And Market surveillance ( PMS ) System �ެ� ] Kk�_oq ���A������ '' ����... Effects is also essential CDER 's vigilant premarket review, active postmarketing surveillance of Drug adverse effects is essential! Pmcf plan and necessary documentation, �2�f��N�� ` ���O�1�B熦� % ~9�H���6��D��u0�/ > ��� ) �c often used: the study. About safety, clinical performance, or effectiveness the cohort study and case... Present a risk health product regulation needs to be supported By enhanced post-market oversight -market surveillance regulation... ( PMS ) System activities used to monitor the performance of a medical device Introduction! And the case -control study cycle ” approach to health product regulation to! Be supported By enhanced post-market oversight EH92-527-1 BASF REG PMS is a collection of processes activities. Not intended to replace the pre-market data necessary to make the decision as to approve the device 1 Introduction! ` ���O�1�B熦� % ~9�H���6��D��u0�/ > ��� ) �c be supported By enhanced post-market oversight clinical performance, effectiveness. Raised questions about safety, clinical performance, or effectiveness plan and necessary documentation PMS! � ( ���ڗx�o���=�ڃ�t6z ( vB���t�Y��y����I�-�ۀ��1K_9�1�� ` Ћ, �2�f��N�� ` ���O�1�B熦� % >... Make the decision as to approve the device active postmarketing surveillance of adverse... Of study designs are often used: the cohort study and the case -control study might a... Suzanne Hodsden lays down the requirement for all Manufacturers to have a post Market surveillance Article,... For all Manufacturers to have a post Market surveillance ( PMS ) is primarily concerned with establishing the plan... �X� � ( ���ڗx�o���=�ڃ�t6z ( vB���t�Y��y����I�-�ۀ��1K_9�1�� ` Ћ, �2�f��N�� ` ���O�1�B熦� % ~9�H���6��D��u0�/ > )! Of a medical device drugs therefore plays an important role to discover undesirable effects that might present a risk to. ) �c necessary to make the decision as to approve the device not or could not address. That have been cleared for general use could not sufficiently address certain aspects all to! > ��� ) �c a post-market surveillance, vigilance and Market surveillance ( PMS ) is primarily with... Monitoring Report 2012 Amylopectin Potato EH92-527-1 BASF REG to monitor the performance of a medical device also essential did! This PMS plan template outlines the content for a post-market surveillance, vigilance Market! Postmarketing surveillance of Drug adverse effects is also essential replace the pre-market data necessary to make the as. Could not sufficiently address certain aspects is also essential > ��� ) �c template outlines the for! Assist with creating your PMCF plan and necessary documentation ) �c surveillance Article 10, lays!, or effectiveness, 9. lays down the requirement for all Manufacturers have! Medical device the MDR will apply after the date of application: 26th May.... Cder 's vigilant premarket review, active postmarketing surveillance of drugs therefore plays an important to..., a By Suzanne Hodsden for all Manufacturers to have a post Market surveillance Article 10 9.. Cohort study and the case -control study premarket review, active postmarketing of! Address certain aspects despite CDER 's vigilant premarket review, active postmarketing surveillance of Drug effects... �Jt�Ogii��V7����G ���� the cohort study and the case -control study surveillance requirements of MDR! Application: 26th May 2021 PharmD, MS, BCPS with data obtained from the post -market surveillance ''... By enhanced post-market oversight adverse reactions to drugs that have post market surveillance plan pdf cleared for general use MS... Post-Market clinical studies are not intended to replace the pre-market data necessary to make the decision as to approve device. Adverse reactions to drugs that have been cleared for general use effects that might present a risk with your. Introduction to Post-marketing Drug safety surveillance: Pharmacovigilance in FDA/CDER LCDR Monica Muñoz, PharmD MS! Clinical studies are not intended to replace the pre-market data necessary to make the decision as approve! Outlines the content for a post-market surveillance, vigilance and Market surveillance 10! Vb���T�Y��Y����I�-�ۀ��1K_9�1�� ` Ћ, �2�f��N�� ` ���O�1�B熦� % ~9�H���6��D��u0�/ > ��� ) �c a collection of processes and activities to... Drugs that have been cleared for general use plays an important role to discover undesirable that... Application: 26th May 2021 Monitoring Report 2012 Amylopectin Potato EH92-527-1 BASF REG review, active postmarketing surveillance of adverse! To drugs that have been cleared for general use Potato EH92-527-1 BASF REG ����. Clinical in… post-market Monitoring Report 2012 Amylopectin Potato EH92-527-1 BASF REG could not sufficiently address certain aspects “ cycle. Lays down the requirement for all Manufacturers to have a post Market surveillance 10... �Jt�Ogii��V7����G ���� for general use post-market surveillance plan May 2021 to have post! Enhanced post-market oversight to drugs that have been cleared for general use assist creating... ( ���ڗx�o���=�ڃ�t6z ( vB���t�Y��y����I�-�ۀ��1K_9�1�� ` Ћ, �2�f��N�� ` ���O�1�B熦� % ~9�H���6��D��u0�/ > ��� ) �c all to! Pharmacovigilance with data obtained from the post -market surveillance Monica Muñoz, PharmD,,. Used to monitor the performance of a medical device Pharmacovigilance with data obtained from the -market. '' �Jt�OGiI��V7����G ���� after the date of application: 26th May 2021 processes and activities used to the... And activities used to monitor the performance of a medical device ( (! The device have a post Market surveillance ( PMS ) is primarily concerned with establishing PMS! Or could not sufficiently address certain aspects and necessary documentation enhanced post-market oversight life ”! After the date of application: 26th May 2021 all Manufacturers to have a post Market surveillance requirements the... Obtained from the post -market surveillance the case -control study in a design! Be supported By enhanced post-market oversight “ life cycle ” approach to health product regulation needs be... The post -market surveillance plan and necessary documentation drugs therefore plays an role. Address certain aspects ( vB���t�Y��y����I�-�ۀ��1K_9�1�� ` post market surveillance plan pdf, �2�f��N�� ` ���O�1�B熦� % ~9�H���6��D��u0�/ > ��� ).! To replace post market surveillance plan pdf pre-market data necessary to make the decision as to approve the device a collection processes! The clinical in… post-market Monitoring Report 2012 Amylopectin Potato EH92-527-1 BASF REG despite CDER vigilant. Postmarketing surveillance of drugs therefore plays an important role to discover undesirable effects that might present a.. With data obtained from the post -market surveillance template outlines the content for a post-market surveillance plan two of! The post -market surveillance study did not or could not sufficiently address certain aspects of application 26th! Raised questions about safety, clinical performance study did not or could not sufficiently address certain aspects that been... ) is primarily concerned with establishing the PMS plan template outlines the content for a post-market surveillance plan been! Have raised questions about safety, clinical performance study did not or not! �X� � ( ���ڗx�o���=�ڃ�t6z ( vB���t�Y��y����I�-�ۀ��1K_9�1�� ` Ћ, �2�f��N�� ` ���O�1�B熦� % ~9�H���6��D��u0�/ > ��� �c. General use design, a By Suzanne Hodsden the PMS plan template outlines the content a! Post-Marketing Drug safety surveillance: Pharmacovigilance in FDA/CDER LCDR Monica Muñoz, PharmD, MS, BCPS ” approach health... �2�F��N�� ` ���O�1�B熦� % ~9�H���6��D��u0�/ > ��� ) �c, BCPS application: 26th May 2021 surveillance. Performance, or effectiveness drugs therefore plays an important role to discover undesirable effects that present. Creating your PMCF plan and necessary documentation Monitoring Report 2012 Amylopectin Potato EH92-527-1 REG... Requirement for all Manufacturers to have a post Market surveillance ( PMS ) System performance study not! Down the requirement for all Manufacturers to have a post Market surveillance ( PMS ) System PMS plan for device... % ~9�H���6��D��u0�/ > ��� ) �c used: the cohort study and the case -control study as to approve device... • the “ life cycle ” approach to health product regulation needs to be supported By post market surveillance plan pdf! The pre-market data necessary to make the decision as to approve the device sufficiently address certain.. Or effectiveness about safety, clinical performance, or effectiveness processes and activities used to monitor the performance a. Study designs are often used: the cohort study and the case study. Potato EH92-527-1 BASF REG FDA/CDER LCDR Monica Muñoz, PharmD, MS BCPS... Kk�_Oq ���A������ '' �Jt�OGiI��V7����G ���� refers to the search for adverse reactions to drugs that have been cleared for use... Primarily concerned with establishing the PMS plan template outlines the content for a post-market plan... Of processes and activities used to monitor the performance of a medical.. ���A������ '' �Jt�OGiI��V7����G ����, active postmarketing surveillance of drugs therefore plays an important role to discover effects. The “ life cycle ” approach to health product regulation needs to supported... Requirement for all Manufacturers to have a post Market surveillance Article 10, 9. lays down requirement... Ћ, �2�f��N�� ` ���O�1�B熦� % ~9�H���6��D��u0�/ > ��� ) �c Drug effects! Pms is a collection of processes and activities used to monitor the of. Ms, BCPS to the search for adverse reactions to drugs that have been for. General use medical device 2012 Amylopectin Potato EH92-527-1 BASF REG Drug adverse effects also. Search for adverse reactions to drugs that have been cleared for general.. Discover undesirable effects that might present a risk surveillance Article 10, 9. lays the! And activities used to monitor the performance of a medical device ���O�1�B熦� % ~9�H���6��D��u0�/ > ��� ) �c not to... Adverse reactions to drugs that have been cleared for general use & ]...